Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtronic's Kappa 700 pacer to offer ease-of-use advantages over recently introduced Kappa 400.

This article was originally published in The Gray Sheet

Executive Summary

MEDTRONIC KAPPA 700 PACEMAKER PHYSICIAN EASE OF USE COULD BE KEY SELLING POINT to doctors unfamiliar and/or uncomfortable with high-tech features offered by next-generation pacemakers, Mario Talejic, MD, University of Montreal, and a clinical investigator of the Kappa 700 suggested. Speaking at a Feb. 3 session of the Piper Jaffray medical device conference in New York City, Talejic said that the Kappa 700 also is intended to streamline implant procedures and reduce the amount of time needed for patient follow-up.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009558

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel